APHA urges U.
Benjamin, MD, FACP, FACEP , executive director of APHA. Passing this measure will strengthen our open public health system, invest in prevention, improve the wellness of the American people and move us closer to providing extensive and affordable health coverage for all People in america. If not today, when? A fresh issue short APHA released today underscores the difficulties that have plagued attempts to pass wellness reform since Teddy Roosevelt’s presidency. Ninety-Eight Years of Almost: The Push for National Health Insurance reveals the powerful effect of special interests against national medical health insurance and the political problems and misfortunes that have stymied progress. After 98 years of almost passing wellness reform legislation, the proper time has come to act, said Benjamin..Financial terms of the transaction include a $10 million up-front payment and a $25 million development milestone payment upon NDA authorization of an EIR formulation rifaximin item for Crohn’s disease. Salix will pay sales-based milestones in respect of EIR formulation also rifaximin products for Crohn’s disease, if product sales targets are achieved, plus royalties on product sales of most EIR formulation rifaximin products. Alfa Wassermann will produce Salix’s requirements of EIR formulation rifaximin products. Commenting on the transaction, Carolyn Logan, President and CEO, Salix, stated, ‘We believe gastrointestinal-specific oral antibiotic rifaximin provides the potential to take care of numerous gastrointestinal diseases.